BIOMAT Database Logo BIOMAT Database Logo

Possible nafcillin-warfarin interaction. 1994

G M Heilker, and J W Fowler, and T H Self

UI MeSH Term Description Entries
D009254 Nafcillin A semi-synthetic antibiotic related to penicillin. Naphthamidopenicillin,Sodium Nafcillin,Nafcil,Nafcillin Sodium,Nafcillin, Monosodium Salt, Anhydrous,Nafcillin, Sodium,Sodium, Nafcillin
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

G M Heilker, and J W Fowler, and T H Self
Warfarin-nafcillin interaction.
February 1991, The Journal of pediatrics,
G M Heilker, and J W Fowler, and T H Self
Significant drug-drug interaction between warfarin and nafcillin.
November 2018, Therapeutic advances in drug safety,
G M Heilker, and J W Fowler, and T H Self
Continuation of warfarin-nafcillin interaction during dicloxacillin therapy.
August 1994, The Journal of family practice,
G M Heilker, and J W Fowler, and T H Self
Decreased hypoprothrombinemic response to warfarin secondary to the warfarin-nafcillin interaction.
June 1991, DICP : the annals of pharmacotherapy,
G M Heilker, and J W Fowler, and T H Self
Possible troglitazone-warfarin interaction.
May 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
G M Heilker, and J W Fowler, and T H Self
Possible warfarin-erythromycin interaction.
July 1980, Archives of internal medicine,
G M Heilker, and J W Fowler, and T H Self
Warfarin resistance with nafcillin therapy.
April 1984, Annals of internal medicine,
G M Heilker, and J W Fowler, and T H Self
Interaction between warfarin and nafcillin: case report and review of the literature.
October 2007, Pharmacotherapy,
G M Heilker, and J W Fowler, and T H Self
Warfarin resistance associated with nafcillin therapy.
August 1989, The American journal of medicine,
G M Heilker, and J W Fowler, and T H Self
Moricizine-warfarin: a possible drug interaction.
January 1992, The Annals of pharmacotherapy,
Copied contents to your clipboard!